Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Tang, Yi-Hui , Lin, Guan-Jie, Ma, Yu‐Bin , Desiderio, Jacopo , Li, Ping , Lü, Jun, Cao, Long‐Long, Zheng, Chao‐Hui , Parisi, Amilcare , Truty, Mark J. , Huang, Chang‐Ming , Lin, Jian‐Xian , Xie, Jian‐Wei , Wang, Jia-Bin , Chen, Qi‐Yue , Lin, Mi , Tu, Ru‐Hong

Mayo Clinic

JAMA Network Open | April 1, 2022 | Volume: 5 | Issue: 4 | Pages: e225557

10.1001/jamanetworkopen.2022.5557 | PMID 35363268 Get It

Biomarker clustering in autosomal dominant Alzheimer's disease
Luckett, Patrick H. , Chen, Charlie, Gordon, Brian A. , Wisch, Julie K. , Berman, Sarah , Chhatwal, Jasmeer P. , Cruchaga, Carlos , Fagan, Anne M. , Farlow, Martin R. , Fox, Nick C. , Xiong, Chengjie , Masters, Colin L. , Mori, Hiroshi , Noble, James M. , Salloway, Stephen , Cash, David M. , Fulham, Michael , Jack, Clifford R. , Vöglein, Jonathan , Klunk, William E. , Wang, Qing , Marcus, Daniel C. , Koudelis, Deborah, Cash, Lisa, Hornbeck, Russ C. , Perrin, Richard J. , Hassenstab, Jason , Morris, John C. , Bateman, Randall J. , (DIAN), for the Dominantly Inherited Alzheimer Network, Cruchaga, Carlos , Jack, Clifford R , Gordon, Brian A , Bateman, Randall J , Masters, Colin L , Vöglein, Jonathan , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Morris, John C , Cash, David M , Wisch, Julie K , Berman, Sarah , Noble, James M , Jucker, Mathias , Schofield, Peter R. , Brickman, Adam M. , Brooks, William S. , Ghetti, Bernardino , Koeppe, Robert A. , Su, Yi , Weiner, Michael W. , Marcus, Daniel, Joseph‐Mathurin, Nelly , Xiong, Chengjie , Karch, Celeste M. , McDade, Eric , Benzinger, Tammie L.S. , Ances, Beau M. , (DIAN), for the Dominantly Inherited Alzheimer Network

Mayo Clinic

Alzheimer's & Dementia | April 1, 2022 | Volume: 19 | Issue: 1 | Pages: 274-284

10.1002/alz.12661 | PMID 35362200 Get It

AbstractINTRODUCTIONAs the number of biomarkers used to study Alzheimer's disease (AD) continues to increase, it is important to understand the utility of any given biomarker, as well as what additional information a biomarker provides when compared to others.METHODSWe used hierarchical clustering to group 19 cross‐sectional biomarkers in autosomal dominant AD. Feature selection identified biomarkers that were the strongest predictors of mutation status and estimated years from symptom onset (EYO). Biomarkers identified included clinical assessments, neuroimaging, cerebrospinal fluid amyloid, and tau, and emerging biomarkers of neuronal integrity and inflammation.RESULTSThree primary clusters were identified: neurodegeneration, amyloid/tau, and emerging biomarkers. Feature selection identified amyloid and tau measures as the primary predictors of mutation status and EYO. Emerging biomarkers of neuronal integrity and inflammation were relatively weak predictors.DISCUSSIONThese results provide novel insight into our understanding of the relationships among biomarkers and the staging of biomarkers based on disease progression.
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Klonoff, David C. , Wang, Jing , Rodbard, David , Kohn, Michael A. , Li, Chengdong , Liepmann, Dorian , Kerr, David , Ahn, David , Peters, Anne L. , Umpierrez, Guillermo E. , Xu, Nicole Y. , Nguyen, Kevin T. , Simonson, Gregg D. , Agus, Michael S. D. , Armaiz-Peña, Gustavo , Basu, Ananda , Battelino, Tadej , Yeshiwas, Sewagegn , Bequette, B. Wayne , Blevins, Thomas , Breton, Marc D. , Castle, Jessica R. , Close, Kelly L. , Drincic, Angela, Dungan, Kathleen , Ejskjær, Niels , Espinoza, Juan , Fleming, G. Alexander , Forlenza, Gregory P. , Freckmann, Guido , Galindo, Rodolfo J. , Gómez, Ana María , Gutow, Hanna A. , Hovorka, Roman , Ji, Linong , Joubert, Michaël , Koliwad, Suneil K. , Lal, Rayhan , Lansang, M. Cecilia , Lee, Wei-An , Leelarathna, Lalantha , Lind, Marcus , Mahoney, Katherine , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras , Mayorov, Alexander Yur'evich , Messler, Jordan , Mohan, Viswanathan , Nichols, James H. , O’Neal, David N. , Pasquel, Francisco J. , Philis‐Tsimikas, Athena , Phillip, Moshe , Rayman, Gerry , Russell, Steven J. , Spanakis, Elias K. , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E. , Wolpert, Howard , Zilbermint, Mihail , Kovatchev, Boris , Seley, Jane Jeffrie , Xu, Nicole Y , Nguyen, Kevin T , Simonson, Gregg , Agus, Michael S D , Al-Sofiani, Mohammed E , Armaiz-Pena, Gustavo , Bailey, Timothy S , Basu, Ananda , Battelino, Tadej , Bekele, Sewagegn Yeshiwas , Benhamou, Pierre-Yves , Bequette, B Wayne , Blevins, Thomas , Breton, Marc D , Castle, Jessica R , Chase, James Geoffrey , Chen, Kong , Choudhary, Pratik , Clements, Mark A , Close, Kelly L , Cook, Curtiss B , Doyle, Francis J , Drincic, Angela , Dungan, Kathleen M , Edelman, Steven V , Ejskjaer, Niels , Espinoza, Juan , Fleming, G Alexander , Forlenza, Gregory P , Freckmann, Guido , Galindo, Rodolfo J , Gomez, Ana Maria , Gutow, Hanna A , Heinemann, Lutz , Hirsch, Irl B , Hoang, Thanh D , Hovorka, Roman , Jendle, Johan H , Ji, Linong , Joshi, Shashank R , Joubert, Michael , Koliwad, Suneil K , Lal, Rayhan A , Lansang, M Cecilia , Lee, Wei-An Andy , Leelarathna, Lalantha , Leiter, Lawrence A , Lind, Marcus , Litchman, Michelle L , Mader, Julia K , Mahoney, Katherine M , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras N , Mayorov, Alexander , Messler, Jordan , Miller, Joshua D , Mohan, Viswanathan , Nichols, James H , Nørgaard, Kirsten , O'Neal, David N , Pasquel, Francisco J , Philis-Tsimikas, Athena , Pieber, Thomas , Phillip, Moshe , Polonsky, William H , Pop-Busui, Rodica , Rayman, Gerry , Rhee, Eun-Jung , Russell, Steven J , Shah, Viral N , Sherr, Jennifer L , Sode, Koji , Spanakis, Elias K , Wake, Deborah J , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E , Wolpert, Howard , Wright, Eugene E , Zilbermint, Mihail , Kovatchev, Boris , Kohn, Michael , Umpierrez, Guillermo E. , Peters, Anne L , Ahn, David T , Liepmann, Dorian , Bailey, Timothy S. , Chen, Kong Y. , Choudhary, Pratik , Cook, Curtiss B. , Danne, Thomas , Doyle, Francis J. , Heinemann, Lutz , Hirsch, Irl B. , Leiter, Lawrence A. , Mader, Julia K. , Pop‐Busui, Rodica , Shah, Viral N. , Sode, Koji , Wright, Eugene E.

Mayo Clinic

Journal of Diabetes Science and Technology | March 29, 2022 | Volume: 17 | Issue: 5 | Pages: 1226-1242

10.1177/19322968221085273 | PMID 35348391 Get It

Background: A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data. Methods: We assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low–glucose and low-glucose hypoglycemia; very high–glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation. Results: The analysis showed that clinician rankings depend on two components, one related to hypoglycemia that gives more weight to very low-glucose than to low-glucose and the other related to hyperglycemia that likewise gives greater weight to very high-glucose than to high-glucose. These two components should be calculated and displayed separately, but they can also be combined into a single Glycemia Risk Index (GRI) that corresponds closely to the clinician rankings of the overall quality of glycemia (r = 0.95). The GRI can be displayed graphically on a GRI Grid with the hypoglycemia component on the horizontal axis and the hyperglycemia component on the vertical axis. Diagonal lines divide the graph into five zones (quintiles) corresponding to the best (0th to 20th percentile) to worst (81st to 100th percentile) overall quality of glycemia. The GRI Grid enables users to track sequential changes within an individual over time and compare groups of individuals. Conclusion: The GRI is a single-number summary of the quality of glycemia. Its hypoglycemia and hyperglycemia components provide actionable scores and a graphical display (the GRI Grid) that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.
A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women
Chen, Hongjie , Middha, Pooja , Bolla, Manjeet K. , Wang, Qin , Michailidou, Kyriaki , Hopper, John L. , Shibli, Rana , Aronson, Kristan J. , Hodge, James M. , Brenner, Hermann , Hoppe, Reiner , Lo, Wing‐Yee, Mannermaa, Arto , Kosma, Veli‐Matti , Jung, Audrey , Haiman, Christopher A. , Simard, Jacques , Goldberg, Mark S. , García‐Closas, Montserrat , Yang, Rose, Evans, D. Gareth , Howell, Anthony , Orr, Nick , Wang, Sophia , Easton, Douglas F. , Chang‐Claude, Jenny , Lindström, Sara , Winham, Stacey, Evans, D Gareth , Brenner, Hermann , Kapoor, Pooja Middha , García-Closas, Montserrat , Michailidou, Kyriaki , Hodge, James M , Simard, Jacques , Wang, Sophia S , Jung, Audrey Y , Orr, Nick , Wang, Xiaoliang , Su, Yu-Ru , Dennis, Joe , Dunning, Alison M. , Lush, Michael J. , Pharoah, Paul D.P. , Southey, Melissa C. , Koutros, Stella , Freeman, Laura E. Beane , Stone, Jennifer , Rennert, Gad , Murphy, Rachel A. , Guénel, Pascal , Truong, Thérèse , Teras, Lauren R. , Canzian, Federico , Kaaks, Rudolf , Arndt, Volker , Behrens, Sabine , Becher, Heiko , Giles, Graham G. , Maskarinec, Gertraud , Scott, Christopher G. , Winham, Stacey J. , Zheng, Wei , Long, Jirong , Troester, Melissa A. , Love, Michael I. , Peng, Cheng , Tamimi, Rulla M. , Eliassen, A. Heather , Figueroa, Jonine D. , Ahearn, Thomas U. , Hall, Per N , Czene, Kamila , Wolk, Alicja , Sandler, Dale P. , Taylor, Jack A. , Swerdlow, Anthony J. , Lacey, James V. , Olsson, Håkan , Milne, Roger L. , Hsu, Li , Kraft, Peter

Mayo Clinic

Cancer Research Communications | March 25, 2022 | Volume: 2 | Issue: 4 | Pages: 211-219

10.1158/2767-9764.crc-21-0119 | PMID 36303815 Get It

Genome-wide association studies (GWAS) have identified more than 200 susceptibility loci for breast cancer, but these variants explain less than a fifth of the disease risk. Although gene–environment interactions have been proposed to account for some of the remaining heritability, few studies have empirically assessed this. We obtained genotype and risk factor data from 46,060 cases and 47,929 controls of European ancestry from population-based studies within the Breast Cancer Association Consortium (BCAC). We built gene expression prediction models for 4,864 genes with a significant (P < 0.01) heritable component using the transcriptome and genotype data from the Genotype-Tissue Expression (GTEx) project. We leveraged predicted gene expression information to investigate the interactions between gene-centric genetic variation and 14 established risk factors in association with breast cancer risk, using a mixed-effects score test. After adjusting for number of tests using Bonferroni correction, no interaction remained statistically significant. The strongest interaction observed was between the predicted expression of the C13orf45 gene and age at first full-term pregnancy (PGXE = 4.44 × 10−6). In this transcriptome-informed genome-wide gene–environment interaction study of breast cancer, we found no strong support for the role of gene expression in modifying the associations between established risk factors and breast cancer risk. Our study suggests a limited role of gene–environment interactions in breast cancer risk.
Differences in postoperative quality of life in young, early elderly, and late elderly patients undergoing surgical treatment for degenerative cervical myelopathy
Croci, Davide M., Sherrod, Brandon, Alvi, Mohammed Ali, Mummaneni, Praveen V., Chan, Andrew K., Bydon, Mohamad, Glassman, Steven D., Foley, Kevin T., Potts, Eric A., Shaffrey, Mark E., Coric, Domagoj, Knightly, John J., Park, Paul, Wang, Michael Y., Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L., Than, Khoi D., Gottfried, Oren N., Shaffrey, Christopher I., Virk, Michael S., Bisson, Erica F., Park, Paul , Alvi, Mohammed Ali , Alvi, Mohammed Ali , Croci, Davide M., Sherrod, Brandon, Alvi, Mohammed Ali, Mummaneni, Praveen V., Chan, Andrew K., Bydon, Mohamad, Glassman, Steven D., Foley, Kevin T., Potts, Eric A., Shaffrey, Mark E., Coric, Domagoj, Knightly, John J., Park, Paul, Wang, Michael Y., Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L., Than, Khoi D., Gottfried, Oren N., Shaffrey, Christopher I., Virk, Michael S., Bisson, Erica F.

Mayo Clinic

Journal of Neurosurgery: Spine | March 25, 2022 | Volume: 37 | Issue: 3 | Pages: 339-349

10.3171/2022.1.spine211157 | PMID 35276658 Get It

OBJECTIVE Cervical spondylotic myelopathy (CSM) is a common progressive spine disorder affecting predominantly middle-aged and elderly populations. With increasing life expectancy, the incidence of CSM is expected to rise further. The outcomes of elderly patients undergoing CSM surgery and especially their quality of life (QOL) postoperatively remain undetermined. This study retrospectively reviewed patients to identify baseline differences and validated postoperative patient-reported outcome (PRO) measures in elderly patients undergoing CSM surgery. METHODS The multi-institutional, neurosurgery-specific NeuroPoint Quality Outcomes Database was queried to identify CSM patients treated surgically at the 14 highest-volume sites from January 2016 to December 2018. Patients were divided into three groups: young (< 65 years), early elderly (65–74 years), and late elderly (≥ 75 years). Demographic and PRO measures (Neck Disability Index [NDI] score, modified Japanese Orthopaedic Association [mJOA] score, EQ-5D score, EQ-5D visual analog scale [VAS] score, arm pain VAS, and neck pain VAS) were compared among the groups at baseline and 3 and 12 months postoperatively. RESULTS A total of 1151 patients were identified: 691 patients (60%) in the young, 331 patients (28.7%) in the early elderly, and 129 patients (11.2%) in the late elderly groups. At baseline, younger patients presented with worse NDI scores (p < 0.001) and lower EQ-5D VAS (p = 0.004) and EQ-5D (p < 0.001) scores compared with early and late elderly patients. No differences among age groups were found in the mJOA score. An improvement of all QOL scores was noted in all age groups. On unadjusted analysis at 3 months, younger patients had greater improvement in arm pain VAS, NDI, and EQ-5D VAS compared with early and late elderly patients. At 12 months, the same changes were seen, but on adjusted analysis, there were no differences in PROs between the age groups. CONCLUSIONS The authors’ results indicate that elderly patients undergoing CSM surgery achieved QOL outcomes that were equivalent to those of younger patients at the 12-month follow-up.
Understanding the transcriptional (dys)regulation in progressive supranuclear palsy
Min, Yuhao , Wang, Xue , Reddy, Joseph S. , Nguyen, Thuy , Malphrus, Kimberly G., Carrasquillo, Minerva M. , Allen, Mariet , Ertekin‐Taner, Nilüfer , Crook, Julia E. , Carrasquillo, Minerva M. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | March 23, 2022 | Volume: 17 | Issue: S3 | Pages: No page available

10.1002/alz.050985 Get It

Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics
Liu, Yuanhang , Bhagwate, Aditya , Stephens, Melissa, Harker, Brent W., McDonough, Samantha J., Heinzen, Ethan P. , Frost, Marlene H., Littlepage, Laurie E. , Cunningham, Julie M. , Winham, Stacey J. , Stallings‐Mann, Melody , Vierkant, Robert A. , Hoskin, Tanya L. , Carter, Jodi M. , Pfrender, Michael E. , Radisky, Derek C. , Degnim, Amy C. , Wang, Chen

Mayo Clinic

No container title available | March 21, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1428294/v1 Get It

Abstract BackgroundFormalin-fixed, paraffin-embedded (FFPE) tissues have many advantages for identification of risk biomarkers, including wide availability and potential for extended follow-up endpoints. However, RNA derived from archival FFPE samples has limited quality. Here we identified parameters that determine which FFPE samples have the potential for successful RNA extraction, library preparation, and generation of usable RNAseq data.MethodsWe optimized library preparation protocols designed for use with FFPE samples using seven FFPE and Fresh Frozen replicate pairs, and tested optimized protocols using a study set of 130 FFPE biopsies from women with benign breast disease. Metrics from RNA extraction and preparation procedures were collected and compared with bioinformatics sequencing summary statistics. Finally, a decision tree model was built to learn the relationship between pre-sequencing lab metrics and qc pass/fail status as determined by bioinformatics metrics.ResultsSamples that failed bioinformatics qc tended to have low median sample-wise correlation within the cohort (Spearman correlation < 0.75), low number of reads mapped to gene regions (< 25 million), or low number of detectable genes (11,400 # of detected genes with CPM > 2). The median RNA concentration and pre-capture library Qubit values for qc failed samples were 18.7 ng/ul and 1.68 ng/ul respectively, which were significantly lower than those of qc pass samples (40.8 ng/ul and 5.58 ng/ul). We built a decision tree model based on input RNA concentration, input library qubit values, and achieved an F score of 0.803 in predicting QC status (pass/fail) of FFPE samples. ConclusionsWe provide a bioinformatics quality control recommendation for FFPE samples from breast tissue by evaluating bioinformatic and sample metrics. Our results suggest a minimum concentration of 25 ng/ul FFPE-extracted RNA for library preparation and 1.8 ng/ul pre-capture library output to achieve adequate RNA-seq data for downstream bioinformatics analysis.
Author response: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
Zhang, Yixiao , Sun, Lisha , Ai, Liping, Ma, Qingtian, Qiao, Xinbo , Yang, Jie , Zhang, Hao , Ou, Xunyan, Chen, Guanglei , Xue, Jinqi , Zhao, Yu , Yang, Yongliang , Liu, Caigang , Li, Haonan , Wang, Yining , Zhu, Xudong , Liu, Caigang

Mayo Clinic

No container title available | March 21, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.68481.sa2 Get It

Abstract TP338: Outcomes After Carotid Endarterectomy Among Dual-eligible Medicare-Medicaid Beneficiaries, 2003-2010
Lichtman, Judith H. , Leifheit-Limson, Erica C, Wang, Yun , Brott, Thomas G. , Meschia, James F. , Howard, George , Howard, Virginia J.

Mayo Clinic

Stroke | March 20, 2022 | Volume: 47 | Issue: suppl_1 | Pages: No page available

10.1161/str.47.suppl_1.tp338 Get It

Background: Over 9 million dual-eligible beneficiaries rely on both Medicare and Medicaid to obtain critical medical services. Medicaid serves as a safety net for low-income Medicare beneficiaries with limited assets; however, it is unknown whether dual-eligible patients have comparable outcomes for procedures to non-dual-eligible Medicare beneficiaries. We compared outcomes by dual-eligible status for patients undergoing carotid endarterectomy (CEA). Methods: We identified Medicare fee-for-service beneficiaries aged ≥65y who underwent CEA (ICD-9 38.12) from 2003-2010. Beneficiaries with ≥1m of Medicaid coverage were considered dual eligible. We fit mixed models with a random intercept for state and adjustment for demographics, comorbidities, and symptomatic status to assess the relationship between dual-eligible status and outcomes. Results: A total of 35,832 dual-eligible and 470,134 non-dual-eligible beneficiaries were hospitalized for CEA during the study period. The percentage of dual-eligible CEA patients decreased from 7.9% in 2003 to 6.7% in 2010. Dual eligibles were more likely to be younger, female, of nonwhite race, and living with comorbid conditions (e.g., heart failure, renal failure, diabetes) and symptomatic carotid disease. Dual eligibles had higher 30d composite outcomes including stroke (Table), but the associations with 1y stroke became nonsignificant from 2003-2010. Dual-eligible status was associated with higher 30d and 1y mortality after CEA throughout the study period. Conclusions: Dual-eligible Medicare-Medicaid beneficiaries had worse short-term stroke and mortality outcomes than other beneficiaries, even after adjustment for comorbidities. Our results indicate a need to understand factors contributing to poorer outcomes. Challenges include the split accountability between the two programs and the diverse sociodemographics, clinical characteristics, and generally poorer health of the patients.
Abstract W P283: Race-Ethnic Stroke Disparities in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study - The NINDS Stroke Prevention Intervention Research Program
Gardener, Hannah , Wang, Kefeng , Dong, Chuanhui , Ciliberti-Vargas, Maria A , Carrasquillo, Olveen , García-Rivera, Enid J , Nelson, Joe A, Nobo, Ulises, Robichaux, Mary, Santiago, Fernando, Waters, Michael F. , Zevallos, Juan Carlos , Collaborators, for the FL-PR CReSD Investigators and, Sacco, Ralph L. , Romano, José G. , Burgin, W. Scott , Koch, Sebastian , Meschia, James F. , Rose, David Z. , Rundek, Tatjana , Collaborators, for the FL-PR CReSD Investigators and

Mayo Clinic

Stroke | March 20, 2022 | Volume: 46 | Issue: suppl_1 | Pages: No page available

10.1161/str.46.suppl_1.wp283 Get It

Background: Race-ethnic disparities in stroke care can contribute to inequality in stroke outcomes. We sought to determine the disparities in stroke performance metrics by race-ethnicity in a voluntary stroke registry of Florida and Puerto Rico Get With The Guidelines-Stroke (GWTG-S) data. Methods: Sixty-three sites who had enrolled in the FL-PR Stroke Registry (54 FL; 9 PR) recorded 38,684 ischemic stroke cases from 2010 to 2013. Generalized linear regression models were used to evaluate race-ethnic differences in 7 pre-defined acute stroke performance measures and defect-free care (IV tPA treatment, in-hospital antithrombotic therapy, DVT prophylaxis, antithrombotic therapy at discharge, anticoagulation therapy, statin medication at discharge, and smoking cessation counseling), adjusting for age and region (FL vs. PR). Results: Of acute ischemic stroke cases, 63% were non-Hispanic White (NHW), 18% NH-Black (NHB), and 17% Hispanic. The mean age was 71±14 years. NHW were older (73±14), followed by Hispanics (70±14), and NHB (63±14); p<0.0001. Defect-free care was better among NHB (78%) and NHW (76%) than in Hispanics (68%), p<0.0001. Defect-free care improved over time and the race-ethnic disparity decreased (2010: NHW 61%, NHB 64%, Hispanic 46%, p<0.0001; 2013: 91%, 91%, 86%, p=0.47 respectively). NHW were most likely to receive IV tPA treatment (arrived by 2 hours and treated by 3 hours; 88%) and early antithrombotic treatment (96%). Hispanics were least likely to receive DVT prophylaxis (76%), anticoagulation (92%), statins (89%), and smoking cessation counseling (93%). Conclusions: Race-ethnic disparities in acute stroke care are evident yet decreasing, coinciding with improvements in quality of care over time in Florida and Puerto Rico hospitals participating in GWTG-S. Special stroke quality improvement programs to target areas where performance is less than expected and minimize race-ethnic disparities are necessary to improve stroke care for all Americans.